Candel Therapeutics Inc

CADL

Add to Watchlist

9.830USD

-0.050-0.51%

Close 07/02, 13:00（ET）Quotes delayed by 15 min

720.25MMarket Cap

LossP/E TTM

Candel Therapeutics Inc

9.830

-0.050-0.51%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Candel Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-07-02

Previous score

7.27

Change

The current valuation score of Candel Therapeutics Inc is 7.27, ranking 250 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.74, which is -93.72% below the recent high of -0.61 and -27.31% above the recent low of -12.40.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.